Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
John Abbott's Stock Ratings
Wolfe Research Analyst
John Abbott is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/23/2025
Overall Average Return
4.54%
Smart Score
Overall Average Return Percentile
47th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/18/2024 | CRGY | Buy Now | Crescent Energy | $8.86 | — | John Abbott55% | — | Reinstates | → Outperform | Get Alert |
| 12/08/2023 | VTLE | Buy Now | Vital Energy | $18.60 | 158.06% | John Abbott55% | → $48 | Initiates | → Underperform | Get Alert |
| 11/07/2023 | GRNT | Buy Now | Granite Ridge Resources | $6.39 | 40.85% | John Abbott55% | → $9 | Initiates | → Buy | Get Alert |
| 01/25/2023 | CRGY | Buy Now | Crescent Energy | $8.86 | 58.01% | John Abbott55% | $13 → $14 | Downgrade | Neutral → Underperform | Get Alert |
| 01/25/2023 | CHRD | Buy Now | Chord Energy | $98.80 | 80.16% | John Abbott55% | → $178 | Initiates | → Buy | Get Alert |
| 11/15/2022 | CRGY | Buy Now | Crescent Energy | $8.86 | 69.3% | John Abbott55% | → $15 | Initiates | → Neutral | Get Alert |
| 01/11/2022 | CYAD | Buy Now | Celyad Oncology | — | — | John Abbott55% | $20 → $11 | Maintains | Overweight | Get Alert |
